Article 1 to 10 out of 24 for "display technology"
Ordered by
DIREVO announces validation of bestMab (08 May 2008) New approach for the optimization of therapeutic antibodies generates optiMIRA, an enhanced version of Adalimumab (Humira) , which was generated using displaytechnology. "This is a major technical...
Organon and Dyax enter into therapeutic antibody alliance (19 Jul 2007) proprietary phage displaytechnology to identify antibodies directed towards... products. Dyax's state-of-the-art phage displaytechnology will help us... a bacteriophage. Using this patented phage displaytechnology, known as phage display, Dyax...
Dyax Corp. Issued Seventh U.S. Patent in Its Phage Display Patent Portfolio (03 May 2007) protein displaytechnology. This new patent provides Dyax with additional patent..., through the use of eukaryotic cell surface display. In addition to its seven U.S. patents, Dyax holds several issued patents for phage display in Canada, Israel...
Affibody has obtained a granted patent on the Microbead displaytechnology (16 Feb 2007) principles based on biological systems, such as phage display, the Microbead displaytechnology is a cell free system without the limiting factors associated... selection technology are performed in vitro, i.e. in the test tube, enabling...
Top